The clinical trials for tirzepatide have shown impressive results, with participants losing an average of 15-20% of their body weight over a sustained period when combined with lifestyle modifications
Nearly half of Americans are living with obesity, which is associated with more than 200 related health issues and diseases, including type 2 diabetes
Common side effects include bloating, gas, and cramping
Ambos pueden ayudar a controlar el apetito, mejorar la sensacin de saciedad y apoyar una prdida de peso progresiva bajo supervisin mdica

For most people, the bigger practical factors are: how quickly weight is coming off whether protein intake is adequate whether resistance training is happening consistently whether strength and body composition are being tracked with more than the scale Who This Matters For This article matters most for: people deciding between semaglutide and tirzepatide people already using one of these drugs and worrying about muscle loss adults over 40 who care about strength, function, and frailty risk readers who want a better body-composition result, not just a lower scale number Key Takeaways both semaglutide and tirzepatide can be associated with some lean-mass loss during weight loss current evidence does not justify a blanket claim that one is always harder on muscle tirzepatide may outperform semaglutide on fat-mass reduction in some comparisons, but its effect on fat-free mass remains uncertain the higher-quality question is not just which drug causes more loss, but how do I protect lean mass while losing fat resistance training, protein, and rate of loss still matter more than medication brand name alone What the Evidence Says The strongest practical conclusion is cautious, not absolute

Retatrutide is not yet commercially available, meaning current pricing reflects the grey market peptide landscape rather than pharmaceutical pricing